false
OasisLMS
Catalog
Essentials - Assessment of Patients with Substance ...
Event Recording
Event Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video is a presentation on the assessment of patients with substance use disorders. The narrator, Dr. Gregory Landy, discusses the changes made in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), which eliminated the use of Roman numerals and the multi-axial diagnostic system. He explains the new diagnostic criteria for substance use disorders and the shift to a dimensional approach. Dr. Landy also introduces the acronym SBIRT, which stands for Screening, Brief Intervention, and Referral to Treatment, and explains its purpose and benefits in addressing substance use. He provides an overview of the different screening tools that can be used to assess alcohol and drug use disorders, including the AUDIT, DAST, Opioid Risk Tool, and others. The presentation includes information on the interpretation of screening results, the use of brief interventions for patients at risk, and the importance of comprehensive assessments that include biochemical testing. Dr. Landy explains the different biomarkers used for alcohol testing, such as AST, ALT, MCV, and GGT, as well as direct alcohol biomarkers like ETG and ETS. He also briefly discusses drug testing methods and provides information on the detection timeframes for different substances. The video concludes with a summary of the topics covered and a thank you message.
Keywords
assessment
substance use disorders
DSM-5
dimensional approach
SBIRT
screening tools
brief interventions
comprehensive assessments
biochemical testing
drug testing methods
×
Please select your language
1
English